biological-therapy

Documents about biological-therapy

• SPINK5 variants drive clinical variability in netherton syndrome through Th2/Th17 skewing and influence therapeutic outcomes#309503Recep Tayyip Erdoğan University Institutional Repository
• Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision#780679Europe PMC
• Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery#898771ClinicalTrials.gov
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer#158222ClinicalTrials.gov
• Comparative results of two IGRA tests for determining the specific response against Mycobacterium tuberculosis infection#397922ARPHA OAI-PMH Endpoint
• Discovery of Novel AURKA Inhibitors for Triple-Negative Breast Cancer (TNBC) Therapy via a Hybrid Virtual Screening Pipeline, Biological Evaluation and Molecular Dynamics Simulation.#438966NCBI PubMed Central
• Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer#840432ClinicalTrials.gov
• A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps#911904ClinicalTrials.gov
• Biological Therapy in Treating Patients With Metastatic Cancer#995240ClinicalTrials.gov
• Left bundle branch pacing vs biventricular pacing in heart failure patients undergoing cardiac resynchronization therapy: an updated systematic review and meta-analysis#424553Figshare
• Comparative Effects of Functional Electrical Stimulation and Mirror Therapy for Foot Clearance Among Patients With Sub-acute Stroke#969400ClinicalTrials.gov
• Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity Relationship.#152294NCBI PubMed Central
• First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER study#398713HAL (France)
• Design and evaluation of a novel peptide-EV complex for targeted Alzheimer’s disease therapy#478479Figshare
• Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis#947972Repositorio de Universidad Autónoma de Chile.
• Community Opioid Overdose Prevention and Naloxone Distribution Programs: An Evidence-to-Practice Review#365484Scholar Commons
• Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched study#374504HAL (France)
• The New Era of Intraperitoneal Carboplatin in Ovarian Cancer: From Biological Rationale to Clinical Implementation#465457OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy#614719eScholarship
• Systematic skin cancer screening in patients treated with biologics for chronic inflammatory rheumatic diseases: an 11-year experience#147438HAL (France)
• Regulatory T cell therapies: biological foundations, engineering strategies, and clinical translation#257538HAL (France)
• A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis#806827ClinicalTrials.gov
• Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically#851600ClinicalTrials.gov
• Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood#992114ClinicalTrials.gov
• Personalized antiplatelet therapy: a scoping review on the role of platelet function testing and genotyping in acute coronary syndrome#68446DataCite
• Personalized antiplatelet therapy: a scoping review on the role of platelet function testing and genotyping in acute coronary syndrome#68447DataCite
• Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer#879698ClinicalTrials.gov
• Quantitative imaging for predicting biological response in 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer#374353HAL (France)
• Design, Synthesis, In Vitro Biological Evaluation, and In Silico Analyses of Novel Pyrano[3,4‑b]indole-Containing Compounds as Promising Multitarget Candidates for Alzheimer's Disease and Cancer Therapy.#796624NCBI PubMed Central
• Comparative Effects of Virtual Reality and Proprioceptive Neuromuscular Facilitation in Patients With Parkinson's Disease#862561ClinicalTrials.gov
• Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point Mutation#283906Figshare
• Cost-effectiveness analysis of Sacituzumab Tirumotecan as second-line therapy for EGFR-TKI–resistant, EGFR-Mutated advanced NSCLC in China#298348Figshare
• Synchronous Reactive Oxygen Species Scavenging and Immunomodulation for Autoimmune Uveitis Therapy by a Mannosylated Biomimetic Nanocloak#433192Figshare
• AVATAR versus cognitive-behavioral therapy for medication-resistant auditory hallucination: A systematic review and network meta-analysis#445397Figshare
• Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）#909405ClinicalTrials.gov
• Incidence of tuberculosis in patients with immune-mediated diseases undergone biological therapy: A 10-year observational study in a high-burden region of northeastern Brazil#406564PLOS
• Towards individualized treatment planning for PSMA-targeted radioligand therapy of advanced prostate cancer: from in silico determination of the relative biological effectiveness to image-based red bone marrow dosimetry / Mikhail Rumiantcev ; Betreuer: Guido Böning#661773Deutsche Nationalbibliothek
• Synthesis and design of biologically inspired biocompatible iron oxide nanoparticles for biomedical applications#954824Koc University Digital Collections
• A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.#839075ClinicalTrials.gov
• Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering#922264eScholarship
• Reprogramming human T cell function and specificity with non-viral genome targeting#814708eScholarship
• A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)#842041ClinicalTrials.gov
• Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma#882239ClinicalTrials.gov
• Separable Microneedles Composed of Hyaluronic Acid Derivatives and Acid-Labile Linkages for Transdermal Delivery of Biomimetic Nanoparticles and Synergistic Breast Cancer Therapy#382014Figshare
• Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer#807992ClinicalTrials.gov
• Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy#915305ClinicalTrials.gov
• Transformative Technology for FLASH Radiation Therapy#675977eScholarship
• Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma#889670ClinicalTrials.gov
• Molecular Engineering of Asymmetric Cyanines with Hybridized Local and Charge-Transfer Characteristics for NIR-II Imaging-Guided Type I/II Photodynamic Therapy#391556Figshare
• Biological Therapy in Treating Patients With Advanced Cancer#861768ClinicalTrials.gov